Moreover, an intravenous injection of BM-MSCs into ovalbumin-induced AD mice led to a significant reduction in cell infiltration in skin lesions, decreased serum IgE levels, and suppressed IL-4 expression in both lymph nodes and skin. This evidence concerns the gene IL4 and Alzheimer disease.